|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Processing Collecting necessary data for HSP...
|
Hospira 30-Days Moving RatingEstimated Market Risk |
| 1.75 actual daily | 71 % of total potential |

| 0.56 actual daily | 44 % of total potential |

| 0.32 actual daily | 20 % of total potential |
| Increase Risk-Adjusted return of HSP by adding it to a well-diversified portfolio |
2.33%| 34.75 | 33.94 |
Few days ago at www.sbwire.com Investor in NYSE:HSP Shares Files Lawsuit Against Hospira, Inc. Directors
A lawsuit was filed by a current investor in HSP shares over alleged breaches of fiduciary duty by certain directors at Hospira, Inc. San Diego, CA -- (SBWIRE) -- 01/26/2012 -- The Shareholders Foundation announces that an investor in NYSE: HSP shares ... |
Few days ago at www.4-traders.com HOSPIRA, INC.: Hospira named a Top 50 Organization for Multicultural Busin..
(NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, announced today it has been named as one of the , the largest organization representing diversity-owned businesses throughout the United States. |
Few days ago at localizedusa.com Hospira (HSP) Share Price Target Increased to $38.00 by Analysts at Bank of ...Hospira (HSP) Share Price Target Increased to $38.00 by Analysts at Bank of ...
LocalizedUSA - 20 hours ago
Bank of America (NYSE: BAC) raised their price target on shares of Hospira (NYSE: HSP) to $38.00 in a research note issued on Tuesday. |
Few days ago at www.localizedusa.com Analysts' Downgrades for January, 10th (ADC, ALTH, CNW, DB, DRI, EQY, HSP, KEY ...Analysts' Downgrades for January, 10th (ADC, ALTH, CNW, DB, DRI, EQY, HSP, KEY ...
LocalizedUSA - 4 hours ago
Agree Realty Corp (NYSE: ADC) was downgraded by analysts at Raymond James to an ?outperform? rating. Allos Therapeutics Incorporated (NASDAQ: ALTH) was downgraded by analysts at Zacks Investment Research from an ?outperform? rating to a ?neutral? ... |
Few days ago at www.localizedusa.com Hospira (HSP) Shares Downgraded by Raymond James (RJF) to "Market Perform"
Hospira (NYSE: HSP) was downgraded by equities research analysts at Raymond James (NYSE: RJF) from an ?outperform? rating to a ?market perform? rating in a research note issued to investors on Tuesday. |